Emerging Pharmacological Therapies for Huntington’s Disease:Translational Insights from Recent Clinical Trials

Current Pharmaceutical Biotechnology · Published 2026-07-30 · DOI 10.2174/0113892010447442260727092257

Authors (7)

Bhupesh Chander Semwal, Kuldeep Singh, Ritesh Sharma, Deepak Sharma, Abhishek Sharma, Divya Jain, Mukesh Chandra Sharma

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Semwal, B., Singh, K., Sharma, R., et al. (2026). Emerging Pharmacological Therapies for Huntington’s Disease:Translational Insights from Recent Clinical Trials. Current Pharmaceutical Biotechnology. https://doi.org/10.2174/0113892010447442260727092257

Related articles

• Fight Against Pulmonary Fibrosis: Integrating Mechanistic Insights and Innovative Therapies · Current Pharmaceutical Biotechnology · 2026 · Same journal
• Production, Downstream Processing, and Application of Phycoerythrin: A Review on Progress and Challenges · Current Pharmaceutical Biotechnology · 2026 · Same journal
• Propofol Offers a Promising Therapeutic Strategy Against Sepsis viaInhibiting Rab5a-mediated Intracellular Trafficking of TLR4:A Comprehensive In-silico Investigation · Current Pharmaceutical Biotechnology · 2026 · Same journal
• Advancing Sustainability in Pharmaceutical Industry: IntegratingIndustry 4.0 for Cleaner Production, Packaging and Disposal Practices · Current Pharmaceutical Biotechnology · 2026 · Same journal
• Unveiling Aptamers for Targeted Tumour Therapies and Detection: Systematic Evolution of Ligands by Exponential Enrichment (SELEX) Technology in Oncology · Current Pharmaceutical Biotechnology · 2026 · Same journal
• Unveiling the Threat: A Closer Look at ESKAPE Pathogens Through Clinical Surveillance in Hospitals · Current Pharmaceutical Biotechnology · 2026 · Same journal
• Ultraviolet-A-Enhanced Antibacterial Activities on Gentamicin-ResistantEscherichia coli by Silver Nanorods Synthesized from Callistemonviminalis Leaf Extract · Current Pharmaceutical Biotechnology · 2026 · Same journal
• Exploring the Antidiabetic Potential of Achyranthes aspera: Bioactive Compound Extraction, In vitro Efficacy, and In silico Insights for Glycemic Control · Current Pharmaceutical Biotechnology · 2026 · Same journal
• Hydroxysafflor Yellow A Attenuates Myocardial Ischemia/Reperfusion Injury-induced Platelet Activation: Role of Mitochondrial Function andAutophagy · Current Pharmaceutical Biotechnology · 2026 · Same journal
• Mitigation of Cadmium-induced Renal Damage by Meso-2,3-Dimercaptosuccinic Acid and Spirulina: A Comparative Study · Current Pharmaceutical Biotechnology · 2026 · Same journal